KIRASTEN BRASFIELD: Open Payments
NPI 1861998460 · CHATSWORTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 33 payments from 12 companies in 2025. Trend: 2023 $778 · 2024 $362 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $145 |
| Novo Nordisk Inc | 7 | $140 |
| PFIZER INC. | 4 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| Verona Pharma, Inc. | 2 | $34 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Medtronic, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: VRAYLAR, ELIQUIS, CAPLYTA, Ozempic, Wegovy, Ohtuvayre, Rybelsus, INSPIRE.
Industry payments across GA — which companies pay providers there.
